BMY FY 2016 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$121B

FY 2016 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$19.4B+17.3% YoY

Gross Profit

$14.5B74.6% margin

Operating Income

$5.2B26.7% margin

Net Income

$4.5B22.9% margin

EPS (Diluted)

$2.65

Cash Flow

Operating Cash Flow

$3.1B

Free Cash Flow

$1.8B

Stock-Based Comp.

$205M

Balance Sheet

Total Assets

$33.7B

Total Liabilities

$17.4B

Stockholders' Equity

$16.2B

Cash & Equivalents

$4.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19.4B	$16.6B	+17.3%
Gross Profit	$14.5B	$12.8B	+13.2%
Operating Income	$5.2B	$3.9B	+31.5%
Net Income	$4.5B	$1.6B	+184.8%